Randomized Sham-controlled Trial of Targeted Lung Denervation in Patients with Chronic Obstructive Pulmonary Disease (AIRFLOW-3).

Am J Respir Crit Care Med · 2025 · PMC12700255 · PMID 40920914

Europe PMC DOI

hedged sentence

0.0900

closest p · 1.8× alpha

0.0900

boldest claim

The sentences

approached significanceP = 0.09so close (0.05 < p ≤ 0.1)

In terms of impact on the sensation of dyspnea, the mean TDI score at 12 months approached significance between groups ( P = 0.09; Table 3 ).

also in 8,237 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.